Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: A Danish population-based cohort study.

Hansen, Rebekka L; Jørgensen, Tanja S; Egeberg, Alexander; Rosenø, Nana A L; Skougaard, Marie; Stisen, Zara R; Dreyer, Lene; Kristensen, Lars-Erik

Hansen, Rebekka L; Jørgensen, Tanja S; Egeberg, Alexander; Rosenø, Nana A L; Skougaard, Marie; Stisen, Zara R; Dreyer, Lene; Kristensen, Lars-Erik.

Afiliação

Hansen RL; The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark.
Jørgensen TS; The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark.
Egeberg A; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Denmark.
Rosenø NAL; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Skougaard M; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Denmark.
Stisen ZR; The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark.
Dreyer L; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Kristensen LE; Department of Rheumatology, Center of Rheumatic Research Aalborg (CERRA), Aalborg University hospital, Aalborg University, Denmark.

Rheumatology (Oxford) ; 2023 Aug 30.

Article em En | MEDLINE | ID: mdl-37647648

Palavras-chave

IL-17 inhibitors; Psoriatic arthritis; adherence to therapy; switching

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google